- What is the impact of Dovato on overall health and well-being, as determined by Patient Reported Outcomes (PROs) and/or Patient Experience?
- What are the drivers for Dovato decision/choice among PLHIV and physicians?
Please refer to the attached documents below for additional guidance related to this RFP and completing the Concept and Proposal forms.
Responses for this RFP may be submitted now through Dec 9, 2022 at 10:00 PM GMT (London) / 5:00 PM EST (New York)
Just a moment, the page is loading...